Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 6/20 | 0.59 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.56 |
| ▸ | SNCA | P37840 | 2/20 | 0.53 |
| ▸ | F10 | P00742 | 1/20 | 0.52 |
| ▸ | ABAT | P80404 | 1/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.47 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 2/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL69668 | 1.00 | LOXL2 (0.59) | LOXL2TAAR1SNCAF10ABAT | |
| SCHEMBL69667 | 1.00 | LOXL2 (0.59) | LOXL2TAAR1SNCAF10ABAT | |
| SCHEMBL80681 | 0.90 | LMNA (0.49) | LOXL2TAAR1SNCAF10ESR1 | |
| SCHEMBL21241003 | 0.90 | ALDH1A1 (0.48) | LOXL2TAAR1SNCAF10ABAT | |
| SCHEMBL2199868 | 0.86 | LOXL2 (0.59) | LOXL2TAAR1F10ABATHDAC3 | |
| SCHEMBL13885490 | 0.82 | CES2 (0.65) | LOXL2TAAR1F10HDAC3HDAC6 | |
| SCHEMBL203283 | 0.82 | ALDH1A1 (0.61) | LOXL2TAAR1HDAC3HDAC6NCOR2 | |
| Hydrochloric Acid SCHEMBL2450035 | 0.80 | ALDH1A1 (0.58) | LOXL2TAAR1HDAC3HDAC6NCOR2 | |
| Benzylamine SCHEMBL27781209 | 0.79 | LOXL2 (0.93) | LOXL2TAAR1ABATHRH3MAOB | |
| Benzene SCHEMBL734439 | 0.79 | LOXL2 (0.80) | LOXL2TAAR1F10ABATHRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230142736-A1 | POLYPEPTIDE MONOLAYER WITH HIGH POTENTIAL AND HYDROPHOBICITY, AND PREPARATION METHOD AND APPLICATION THEREOF | QILU UNIVERSITY OF TECHNOLOGY (CN) | 2023-05-11 | — | — | US | disclosed |
| US-10753941-B2 | Biocompatible nanoparticles with aggregation induced emission characteristics as fluorescent bioprobes and methods of using the same for in vitro and in vivo imaging | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2020-08-25 | — | — | US | disclosed |
| CN-109665931-A | A kind of new method preparing aggregation luminescent material tetraphenylethylene derivative | 常州大学 | 2019-04-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10753941-B2 | Biocompatible nanoparticles with aggregation induced emission characteristics as fluorescent bioprobes and methods of using the same for in vitro and in vivo imaging | LGALS3, LGALS1, CD63 | LOXL2 1348/4885TAAR1 698/4885SNCA 210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.